Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity*

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current Medical Research and Opinion

• Publication date

  2007-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1185/030079907X159515PMID 17261234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease

  2006cited by this paper
• Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg

  2005cited by this paper
• Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.

  2004cited by this paper
• Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.

  2004cited by this paper
• Who should receive antibiotics for exacerbations of chronic bronchitis? A plea for more outcome-based studies.

  2004influential reference
• Acute exacerbation of chronic bronchitis: a primary care consensus guideline.

  2004cited by this paper
• Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem

  2004cited by this paper
• Canadian guidelines for the management of acute exacerbations of chronic bronchitis.

  2003cited by this paper
• Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.

  2003cited by this paper
• Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis

  2003cited by this paper
• Global initiative for chronic obstructive lung disease.

  2002cited by this paper
• Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

  2002cited by this paper
• Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

  2002cited by this paper
• New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

  2002cited by this paper
• Does increased aromatase activity in adipose fibroblasts cause low sexual desire in patients with HIV lipodystrophy?

  2002cited by this paper
• Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study.

  2001cited by this paper
• Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.

  2001cited by this paper
• Role of Antimicrobial Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

  2001cited by this paper
• Treating acute exacerbations of chronic bronchitis in the face of antibiotic resistance.

  2000cited by this paper
• The role of antimicrobial therapy in acute exacerbations of chronic bronchitis.

  1999cited by this paper
• Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.

  1999cited by this paper
• Clinical Investigations: Inflammation/InfectionInfective Exacerbations of Chronic Bronchitis: Relation between Bacteriologic Etiology and Lung Function

  1998cited by this paper
• Guidelines for the treatment of acute exacerbations of chronic bronchitis.

  1997cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society.

  1995cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.

  1987cited by this paper
• Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

  1987cited by this paper

• Prevalence, Pattern, Risks Factors and Consequences of Antibiotic Resistance in COPD: A Systematic Review

  2021cites this paper
• Contraindications to immunotherapy: a global approach

  2019cites this paper
• Pharmacokinetic and pharmacodynamic differences of new generation, longer-acting basal insulins: potential implications for clinical practice in type 2 diabetes

  2019cites this paper
• Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes

  2018cites this paper
• The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension

  2016cites this paper
• Guidelines for the management of adult lower respiratory tract infections--summary.

  2011cites this paper
• Treatment of Chronic Pain by Long‐Acting Opioids and the Effects on Sleep

  2011cites this paper
• Guidelines for the management of adult lower respiratory tract infections ‐ Full version

  2011cites this paper
• Efficacy of the Sustained-Release Hydromorphone in Neuropathic Pain Management: Pooled Analysis of Three Open-Label Studies

  2010cites this paper
• Update on endothelin‐related diseases

  2009cites this paper
• Potential flaws and biases in a randomized controlled trial (RCT) of insulin determir vs. insulin glargine by Pieber and colleagues

  2008cites this paper
• Reliably assessing the cost‐effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues?

  2007cites this paper
• International Journal of Copd Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Gemifloxacin Use in the Treatment of Acute Bacterial Exacerbation of Chronic Bronchitis

  year unknowncites this paper